Multiple Myeloma Update From the 2013 ASCO Annual Meeting

Program Evaluation

Program Objective:
To provide the latest data that was presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting.

Question Title

* 1. Please take a few moments to rate this program and the speakers.

	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
The program met its stated objective (listed above)	The program met its stated objective (listed above) Strongly Disagree	The program met its stated objective (listed above) Disagree	The program met its stated objective (listed above) Neutral	The program met its stated objective (listed above) Agree	The program met its stated objective (listed above) Strongly Agree
The level of material presented was appropriate	The level of material presented was appropriate Strongly Disagree	The level of material presented was appropriate Disagree	The level of material presented was appropriate Neutral	The level of material presented was appropriate Agree	The level of material presented was appropriate Strongly Agree
The program was easy to access	The program was easy to access Strongly Disagree	The program was easy to access Disagree	The program was easy to access Neutral	The program was easy to access Agree	The program was easy to access Strongly Agree
I will participate in future MMRF-sponsored programs	I will participate in future MMRF-sponsored programs Strongly Disagree	I will participate in future MMRF-sponsored programs Disagree	I will participate in future MMRF-sponsored programs Neutral	I will participate in future MMRF-sponsored programs Agree	I will participate in future MMRF-sponsored programs Strongly Agree

Question Title

* 2. How did you learn about this program? (Indicate all that apply)

Email Invitation

Fast Facts

Word of Mouth

MMRF Website

Other (please specify):

Question Title

* 3. What influenced your decision to attend our program? (Indicate all that apply)

Content

Format

Program Faculty

Other (please specify):

Question Title

* 4. What is your preferred method to receive myeloma information? (Indicate all that apply)

Telephone Education Programs

Web Education Programs

Live Seminars

Online/Internet

Print Materials

Healthcare Provider

CD-Roms/DVDs

Other (please specify):

Question Title

* 5. Please rate the quality of the faculty presentations on a scale of 1 (Poor) to 5 (Excellent)

	Content	Relevance
Initial Therapies	Initial Therapies Content menu	Initial Therapies Relevance menu
New Approaches to Double Refractory Disease	New Approaches to Double Refractory Disease Content menu	New Approaches to Double Refractory Disease Relevance menu
Diagnostic Imaging and Monitoring Multiple Myeloma	Diagnostic Imaging and Monitoring Multiple Myeloma Content menu	Diagnostic Imaging and Monitoring Multiple Myeloma Relevance menu

Question Title

* 6. I am a...

Patient

Patient Spouse

Patient Family Member

Friend

Healthcare Worker

Physician

Other (please specify):

Question Title

* 7. Will the information presented today help influence you to modify or change any aspect of your treatment decisions?

Yes

If yes, please provide an example:

Question Title

* 8. What topics would you like to see presented in future myeloma-specific programs?

Question Title

* 9. Additional comments

Question Title

* 10. Name (Optional)

Question Title

* 11. Email (Optional)

Your input will help us to further develop patient education programs that address the needs of the myeloma community. Thank you for your participation.

* Indicates Response Required